Private Market View

Bloodtest.co.uk

Nottingham, United Kingdom · Founded 2023 · Privately Held (backing)

Last price · $/share
Implied valuation
$17.5M
Total raised
$3.5M
Last round

Key facts

  • Bloodtest.co.uk’s last known valuation is $17.5M (Jul 2025).
  • It has raised $3.5M; the latest was PE Growth/Expansion ($3.5M) in Jul 2025.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·Watchlist + deal alerts for Bloodtest.co.uk
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Bloodtest.co.uk are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Bloodtest.co.uk

Provider of private blood testing services intended to serve across the United Kingdom. The company offers direct access testing services with results and insights delivered digitally, thereby enabling individuals to obtain timely, blood health insights without NHS delays.

Sector
Healthcare
HQ
Nottingham, United Kingdom
Founded
2023
Ownership
Privately Held (backing)
PA Mark — not yet priced

Bloodtest.co.uk doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Bloodtest.co.uk shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Bloodtest.co.uk in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.